Weihuang Liu
- Immunology top 10%
- Immunotherapy and Immune Responses 4
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 3
- Psoriasis: Treatment and Pathogenesis 3
- Signal Processing top 10%
-
- Granular flow and fluidized beds 6
- Cyclone Separators and Fluid Dynamics 3
-
- Cell Image Analysis Techniques 3
-
- Extracellular vesicles in disease 3
-
- Antifungal resistance and susceptibility 3
Weihuang Liu
43 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Immunology 323
- Experimental and Cognitive Psychology 152
- Computer Vision and Pattern Recognition 202
- Signal Processing 89
- Cancer Research 121
Countries citing papers authored by Weihuang Liu
This map shows the geographic impact of Weihuang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihuang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihuang Liu more than expected).
Fields of papers citing papers by Weihuang Liu
This network shows the impact of papers produced by Weihuang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihuang Liu. The network helps show where Weihuang Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weihuang Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 11 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 19 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 27 | |
| 8 | 2023 | 11 | |
| 9 | Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancerbreakdown → | 2022 | 297 |
| 10 | 2022 | 28 | |
| 11 | 2021 | 5 | |
| 12 | 2021 | 23 | |
| 13 | 2020 | 23 | |
| 14 | 2018 | 11 | |
| 15 | 2015 | 1 | |
| 16 | 2014 | 22 | |
| 17 | Comparison and analysis of cutting performance of longitudinal cutting heads with various numbers of helical lines | 2013 | 3 |
| 18 | 2013 | 2 | |
| 19 | 2012 | 124 | |
| 20 | 2012 | 28 |
About Weihuang Liu
Weihuang Liu is a scholar working on Biophysics, Immunology and Computer Vision and Pattern Recognition, having authored 46 papers that have together received 1.2k indexed citations. Recurring topics across this work include Granular flow and fluidized beds (6 papers), Immunotherapy and Immune Responses (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Cyclone Separators and Fluid Dynamics (3 papers), Psoriasis: Treatment and Pathogenesis (3 papers), Cell Image Analysis Techniques (3 papers), Extracellular vesicles in disease (3 papers) and Antifungal resistance and susceptibility (3 papers). The work is most often cited by research in Immunology (323 citations), Experimental and Cognitive Psychology (152 citations) and Computer Vision and Pattern Recognition (202 citations). Weihuang Liu has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Zengwei Yao, Jiahui Pan, Chi‐Man Pun, Xiaodong Cun, Kezhen Yi, Fubing Wang, Chunhui Yuan, Lanxiang Huang, Xuan Tang and Xing Gao. Their work appears in journals such as PLoS ONE, IEEE Transactions on Pattern Analysis and Machine Intelligence and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.